Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.30 -0.20 (-5.65%)
As of: Oct 20, 2026 · 12:58 PM EDT

Apimeds Pharmaceuticals US (APUS) Share-based Compensation (2025)

Updated

Apimeds Pharmaceuticals US (APUS) recorded Share-based Compensation of $1.33 million in Q4 2025.

Analysis

Apimeds Pharmaceuticals US (APUS) Share-based Compensation (2025) Analysis & Trends

For FY2025, Apimeds Pharmaceuticals US reported Share-based Compensation of $1.57 million.

  • Across earlier years, Share-based Compensation came in at $69,993 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,154.60 Bn 1,123.18 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 624.15 Bn 542.68 Bn 17.26 Bn 458.00 Mn
3 AbbVie 512.14 Bn 485.26 Bn 12.70 Bn 166.00 Mn
4 Merck 365.44 Bn 319.81 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 297.27 Bn 261.26 Bn 11.24 Bn -
6 Astrazeneca 261.41 Bn 235.09 Bn 12.86 Bn -
7 Amgen 234.57 Bn 189.96 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 192.90 Bn 167.10 Bn 6.22 Bn 231.00 Mn
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn 249.00 Mn
10 Apimeds Pharmaceuticals US 5.65 Mn -13.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.81 Mn
Sep 30, 2025 42,674.00
Jun 30, 2025 192,053.00
API Access

Apimeds Pharmaceuticals US Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APUS&period=max&api_key=YOUR_API_KEY